Cross Cancer Institute — Edmonton, Alberta

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Edmonton →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Cross Cancer Institute, compiled from the ClinicalTrials.gov public registry.

882

Registered studies

219

Active

97

Recruiting now

522

Completed

97

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · NSCLC (Advanced Non-small Cell Lung Cancer) · B-cell Non-Hodgkin Lymphoma (B-NHL)

Recently updated registry entries

NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)
NCT06073821 — Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax… (Active Not Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.